CXCL10 and cancer: In addition, the proliferative and metastatic potentials conferred by CXCL10-CXCR3-A have been observed in other human cancers, including prostate cancer (Wu Q et al. 2012), gastric cancer (Yang et al. 2016), glioblastoma (Maru et al. 2008), and breast cancer (Kim et al. 2021).